Medications for analgesia and sedation in the intensive care unit: an overview

doi:10.1186/cc6150

Critical Care
Volume 12
Suppl 3

Viewing options:

Abstract
Full text
PDF (269KB)

Associated material:

PubMed record

Related literature:

Articles citing this article
on BioMed Central
on Google Scholar
on ISI Web of Science
on PubMed Central
Other articles by authors
on Google Scholar

Gommers D
Bakker J

on PubMed

Gommers D
Bakker J
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

This article is part of the supplement: Analgesia and sedation in the intensive care unit .

Review

Medications for analgesia and sedation in the intensive care unit: an overview

Diederik Gommers and Jan Bakker

Department of Intensive Care, Erasmus MC, Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands

author email corresponding author email

Critical Care 2008, 12(Suppl 3):S4doi:10.1186/cc6150


Published:	14 May 2008

Abstract

Critically ill patients are often treated with continuous intravenous infusions of sedative drugs. However, this is associated with high risk for over-sedation, which can result in prolonged stay in the intensive care unit. Recently introduced protocols (daily interruption and analgosedation) have proven to reduce the length of intensive care unit stay. To introduce these protocols, new agents or new regimens with the well established agents may be required. In this article we briefly discuss these new regimens and new agents, focusing on the short-acting substances.